MERIDIAN DIAGNOSTICS INC
10-K405/A, EX-27, 2000-08-07
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: MERIDIAN DIAGNOSTICS INC, 10-K405/A, EX-23, 2000-08-07
Next: KING INVESTMENT ADVISORS INC/TX, 13F-HR, 2000-08-07



<TABLE> <S> <C>

<ARTICLE> 5
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1999
<PERIOD-START>                             OCT-01-1998
<PERIOD-END>                               SEP-30-1999
<CASH>                                           6,229
<SECURITIES>                                     1,002
<RECEIVABLES>                                   12,888
<ALLOWANCES>                                       380
<INVENTORY>                                     10,357
<CURRENT-ASSETS>                                31,744
<PP&E>                                          24,193
<DEPRECIATION>                                   9,987
<TOTAL-ASSETS>                                  72,161
<CURRENT-LIABILITIES>                           13,602
<BONDS>                                         20,000
                                0
                                          0
<COMMON>                                         2,424
<OTHER-SE>                                      31,167
<TOTAL-LIABILITY-AND-EQUITY>                    33,591
<SALES>                                         53,927
<TOTAL-REVENUES>                                53,927
<CGS>                                           19,558
<TOTAL-COSTS>                                   19,558
<OTHER-EXPENSES>                                27,842
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               2,143
<INCOME-PRETAX>                                  4,812
<INCOME-TAX>                                     2,739
<INCOME-CONTINUING>                              2,073
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     2,073
<EPS-BASIC>                                       0.14
<EPS-DILUTED>                                     0.14


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission